A Practical Guide for Calculating Indirect Costs of Disease View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1996-11

AUTHORS

Marc A. Koopmanschap, Frans F. H. Rutten

ABSTRACT

There may be some discussion about whether indirect costs should be taken into account at all in an economic appraisal, but there is certainly considerable debate about the proper way of estimating these costs. This reviews offers a practical guide for quantifying and valuing these indirect costs of disease, both at an aggregated level of general cost of illness studies, and in an economic appraisal of specific healthcare programmes. Two methods of calculating these costs are considered: the traditional human capital approach, and the more recently developed friction cost method. The former method estimates the potential value of lost production as a result of disease, whereas the latter method intends to derive more realistic estimates of indirect costs, taking into account the degree of scarcity of labour in the economy. All necessary steps in the estimation procedure and the data required at various points will be described and discussed in detail. More... »

PAGES

460-466

References to SciGraph publications

  • 1993-12. Indirect Costs in Economic Studies in PHARMACOECONOMICS
  • 1992-07. Cost-of-Illness Studies in PHARMACOECONOMICS
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.2165/00019053-199610050-00003

    DOI

    http://dx.doi.org/10.2165/00019053-199610050-00003

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1048630198

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/10172868


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1402", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Applied Economics", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/14", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Economics", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cost-Benefit Analysis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Delivery of Health Care", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Disease Management", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Erasmus University Rotterdam", 
              "id": "https://www.grid.ac/institutes/grid.6906.9", 
              "name": [
                "Medical Faculty, Institute for Medical Technology Assessment, Erasmus University, PO Box 1738, 3000 DR, Rotterdam, The Netherlands"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Koopmanschap", 
            "givenName": "Marc A.", 
            "id": "sg:person.0674561225.75", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0674561225.75"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Erasmus University Rotterdam", 
              "id": "https://www.grid.ac/institutes/grid.6906.9", 
              "name": [
                "Medical Faculty, Institute for Medical Technology Assessment, Erasmus University, PO Box 1738, 3000 DR, Rotterdam, The Netherlands"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Rutten", 
            "givenName": "Frans F. H.", 
            "id": "sg:person.01174260760.93", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174260760.93"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "https://doi.org/10.1016/0167-6296(94)00044-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001908892"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/hec.4730030606", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012420764"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00019053-199202010-00001", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012528385", 
              "https://doi.org/10.2165/00019053-199202010-00001"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1017/s0266462300009764", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018432857"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1017/s0266462300009764", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018432857"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/j.1464-5491.1989.tb02107.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028160306"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/j.1464-5491.1989.tb02107.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028160306"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0014-2921(91)90010-g", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031408943"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00019053-199304060-00006", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033688800", 
              "https://doi.org/10.2165/00019053-199304060-00006"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1136/bmj.291.6491.326", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043394060"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1996-11", 
        "datePublishedReg": "1996-11-01", 
        "description": "There may be some discussion about whether indirect costs should be taken into account at all in an economic appraisal, but there is certainly considerable debate about the proper way of estimating these costs. This reviews offers a practical guide for quantifying and valuing these indirect costs of disease, both at an aggregated level of general cost of illness studies, and in an economic appraisal of specific healthcare programmes. Two methods of calculating these costs are considered: the traditional human capital approach, and the more recently developed friction cost method. The former method estimates the potential value of lost production as a result of disease, whereas the latter method intends to derive more realistic estimates of indirect costs, taking into account the degree of scarcity of labour in the economy. All necessary steps in the estimation procedure and the data required at various points will be described and discussed in detail.", 
        "genre": "research_article", 
        "id": "sg:pub.10.2165/00019053-199610050-00003", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1102812", 
            "issn": [
              "1170-7690", 
              "1179-2027"
            ], 
            "name": "PharmacoEconomics", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "5", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "10"
          }
        ], 
        "name": "A Practical Guide for Calculating Indirect Costs of Disease", 
        "pagination": "460-466", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "e7aa6a92653bd5538e979f2e7304d096ef001ef10f8933c87109f38e28d3b674"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "10172868"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "9212404"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.2165/00019053-199610050-00003"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1048630198"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.2165/00019053-199610050-00003", 
          "https://app.dimensions.ai/details/publication/pub.1048630198"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-10T13:27", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8659_00000569.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "http://link.springer.com/10.2165/00019053-199610050-00003"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.2165/00019053-199610050-00003'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.2165/00019053-199610050-00003'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.2165/00019053-199610050-00003'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.2165/00019053-199610050-00003'


     

    This table displays all metadata directly associated to this object as RDF triples.

    118 TRIPLES      21 PREDICATES      41 URIs      25 LITERALS      13 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.2165/00019053-199610050-00003 schema:about N240007dd8b364e1db523c2b9543211d6
    2 N2dcc03d5d1fc424682ec09f2bd23c3d4
    3 Na4075b4a80054cdda9ce35d31c90aaae
    4 Ne2f9124518e54021b49567f5586cff32
    5 anzsrc-for:14
    6 anzsrc-for:1402
    7 schema:author N25a749fc558c40b3bf4d3102fbe70584
    8 schema:citation sg:pub.10.2165/00019053-199202010-00001
    9 sg:pub.10.2165/00019053-199304060-00006
    10 https://doi.org/10.1002/hec.4730030606
    11 https://doi.org/10.1016/0014-2921(91)90010-g
    12 https://doi.org/10.1016/0167-6296(94)00044-5
    13 https://doi.org/10.1017/s0266462300009764
    14 https://doi.org/10.1111/j.1464-5491.1989.tb02107.x
    15 https://doi.org/10.1136/bmj.291.6491.326
    16 schema:datePublished 1996-11
    17 schema:datePublishedReg 1996-11-01
    18 schema:description There may be some discussion about whether indirect costs should be taken into account at all in an economic appraisal, but there is certainly considerable debate about the proper way of estimating these costs. This reviews offers a practical guide for quantifying and valuing these indirect costs of disease, both at an aggregated level of general cost of illness studies, and in an economic appraisal of specific healthcare programmes. Two methods of calculating these costs are considered: the traditional human capital approach, and the more recently developed friction cost method. The former method estimates the potential value of lost production as a result of disease, whereas the latter method intends to derive more realistic estimates of indirect costs, taking into account the degree of scarcity of labour in the economy. All necessary steps in the estimation procedure and the data required at various points will be described and discussed in detail.
    19 schema:genre research_article
    20 schema:inLanguage en
    21 schema:isAccessibleForFree false
    22 schema:isPartOf Nd1a4cf2f4ebe48cc9edeb017220f6263
    23 Nd6eb71a8e02543baac19cd558c76ab7f
    24 sg:journal.1102812
    25 schema:name A Practical Guide for Calculating Indirect Costs of Disease
    26 schema:pagination 460-466
    27 schema:productId N4b6f127eac414433ab4d62d3e83c87c5
    28 N6ad9ee4e6f984e2d93d55de86a28edf5
    29 N9888ef9474e844138e66a817462cb97d
    30 Nacf06dfbf70e407a8c90e16ac8ddacbe
    31 Nbfebcee1bcd84895b891bde0be76ea31
    32 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048630198
    33 https://doi.org/10.2165/00019053-199610050-00003
    34 schema:sdDatePublished 2019-04-10T13:27
    35 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    36 schema:sdPublisher Nd98919b9f3fa4162a8989422c7e6f947
    37 schema:url http://link.springer.com/10.2165/00019053-199610050-00003
    38 sgo:license sg:explorer/license/
    39 sgo:sdDataset articles
    40 rdf:type schema:ScholarlyArticle
    41 N240007dd8b364e1db523c2b9543211d6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    42 schema:name Disease Management
    43 rdf:type schema:DefinedTerm
    44 N25a749fc558c40b3bf4d3102fbe70584 rdf:first sg:person.0674561225.75
    45 rdf:rest Neeb915598cb14b0fb63949c210781a42
    46 N2dcc03d5d1fc424682ec09f2bd23c3d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    47 schema:name Delivery of Health Care
    48 rdf:type schema:DefinedTerm
    49 N4b6f127eac414433ab4d62d3e83c87c5 schema:name pubmed_id
    50 schema:value 10172868
    51 rdf:type schema:PropertyValue
    52 N6ad9ee4e6f984e2d93d55de86a28edf5 schema:name nlm_unique_id
    53 schema:value 9212404
    54 rdf:type schema:PropertyValue
    55 N9888ef9474e844138e66a817462cb97d schema:name dimensions_id
    56 schema:value pub.1048630198
    57 rdf:type schema:PropertyValue
    58 Na4075b4a80054cdda9ce35d31c90aaae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    59 schema:name Cost-Benefit Analysis
    60 rdf:type schema:DefinedTerm
    61 Nacf06dfbf70e407a8c90e16ac8ddacbe schema:name readcube_id
    62 schema:value e7aa6a92653bd5538e979f2e7304d096ef001ef10f8933c87109f38e28d3b674
    63 rdf:type schema:PropertyValue
    64 Nbfebcee1bcd84895b891bde0be76ea31 schema:name doi
    65 schema:value 10.2165/00019053-199610050-00003
    66 rdf:type schema:PropertyValue
    67 Nd1a4cf2f4ebe48cc9edeb017220f6263 schema:issueNumber 5
    68 rdf:type schema:PublicationIssue
    69 Nd6eb71a8e02543baac19cd558c76ab7f schema:volumeNumber 10
    70 rdf:type schema:PublicationVolume
    71 Nd98919b9f3fa4162a8989422c7e6f947 schema:name Springer Nature - SN SciGraph project
    72 rdf:type schema:Organization
    73 Ne2f9124518e54021b49567f5586cff32 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    74 schema:name Humans
    75 rdf:type schema:DefinedTerm
    76 Neeb915598cb14b0fb63949c210781a42 rdf:first sg:person.01174260760.93
    77 rdf:rest rdf:nil
    78 anzsrc-for:14 schema:inDefinedTermSet anzsrc-for:
    79 schema:name Economics
    80 rdf:type schema:DefinedTerm
    81 anzsrc-for:1402 schema:inDefinedTermSet anzsrc-for:
    82 schema:name Applied Economics
    83 rdf:type schema:DefinedTerm
    84 sg:journal.1102812 schema:issn 1170-7690
    85 1179-2027
    86 schema:name PharmacoEconomics
    87 rdf:type schema:Periodical
    88 sg:person.01174260760.93 schema:affiliation https://www.grid.ac/institutes/grid.6906.9
    89 schema:familyName Rutten
    90 schema:givenName Frans F. H.
    91 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174260760.93
    92 rdf:type schema:Person
    93 sg:person.0674561225.75 schema:affiliation https://www.grid.ac/institutes/grid.6906.9
    94 schema:familyName Koopmanschap
    95 schema:givenName Marc A.
    96 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0674561225.75
    97 rdf:type schema:Person
    98 sg:pub.10.2165/00019053-199202010-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012528385
    99 https://doi.org/10.2165/00019053-199202010-00001
    100 rdf:type schema:CreativeWork
    101 sg:pub.10.2165/00019053-199304060-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033688800
    102 https://doi.org/10.2165/00019053-199304060-00006
    103 rdf:type schema:CreativeWork
    104 https://doi.org/10.1002/hec.4730030606 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012420764
    105 rdf:type schema:CreativeWork
    106 https://doi.org/10.1016/0014-2921(91)90010-g schema:sameAs https://app.dimensions.ai/details/publication/pub.1031408943
    107 rdf:type schema:CreativeWork
    108 https://doi.org/10.1016/0167-6296(94)00044-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001908892
    109 rdf:type schema:CreativeWork
    110 https://doi.org/10.1017/s0266462300009764 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018432857
    111 rdf:type schema:CreativeWork
    112 https://doi.org/10.1111/j.1464-5491.1989.tb02107.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1028160306
    113 rdf:type schema:CreativeWork
    114 https://doi.org/10.1136/bmj.291.6491.326 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043394060
    115 rdf:type schema:CreativeWork
    116 https://www.grid.ac/institutes/grid.6906.9 schema:alternateName Erasmus University Rotterdam
    117 schema:name Medical Faculty, Institute for Medical Technology Assessment, Erasmus University, PO Box 1738, 3000 DR, Rotterdam, The Netherlands
    118 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...